SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is surging after exceeding earnings expectations, fueled by an 84% jump in cloud infrastructure revenue and a substantial increase in remaining performance obligations that signal robust AI-driven demand, reassuring investors about its growth trajectory and capacity funding. The community is actively discussing Oracle's transformation into a key AI infrastructure provider, anticipating further price action and a potential short squeeze.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp is trending as it prepares for its uplisting to the NYSE, with its CEO gaining significant media exposure discussing the company's strategic importance. This comes amid community excitement over a recent Department of War award to expand antimony production and a major tungsten resource discovery, reinforcing its critical role in national defense and technology.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as recent in-line CPI data is met with skepticism amidst escalating Middle East tensions and concerns over global oil supply, fueling community debate on market stability and future inflation.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trending amid heightened volatility, driven by conflicting reports surrounding the Iran conflict's impact on oil, alongside in-line CPI data and strong Oracle earnings that are providing a lift to the tech-heavy index; however, the community widely debates market manipulation and the sustainability of recent rallies.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Round Rock, TX.

TSS Inc

TSS Inc. is surging following exceptional Q4 earnings that significantly beat expectations, driven by strong AI rack integration demand and an extended multi-year agreement with its largest customer. The community is actively discussing the potential for a massive short squeeze as the company projects doubling its AI integration volumes amid the broader data center buildout.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending following a flurry of strategic partnerships, including deploying Amazon's Zoox robotaxis and Joby's air taxis, alongside investments in autonomous vehicle infrastructure and the acquisition of SpotHero. The community is buzzing about Uber's aggressive expansion into a comprehensive mobility ecosystem through these collaborations, though some express frustration over the stock's recent performance despite the positive long-term vision.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending with high anticipation for its upcoming earnings report, as its recent AIUC-1 certification highlights its role in secure enterprise AI agent orchestration, driving polarized community discussion and short-squeeze speculation.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as NVIDIA confirms a $2 billion strategic investment to scale its AI cloud infrastructure, further bolstered by approval for a massive 1.2 GW AI factory and growing customer demand exemplified by upfront payments for capacity. The community views these developments as strong validation, solidifying NBIS's leadership in the rapidly expanding AI data center sector.

CitroTech, Inc. is an integrated environmental service company, which engages in the provision of field services, remediation transportation, and EHS compliance services. It also offers on-site technical services, on-site and off-site treatment for hazardous and non-hazardous waste. The company was founded on March 14, 1990 and is headquartered in Cheyenne, WY.

CitroTech Inc.

CitroTech Inc. is trending as its unique EPA Safer Choice certified fire prevention technology and initial commercial lumber rollout gain significant institutional and retail investor attention following a recent conference. The company's tight share float and strong narrative around escalating wildfire prevention needs are driving discussions of potential re-rating and further momentum.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is seeing intense volatility as investors balance a flight to safety against rising oil prices and a hotter-than-expected PPI report, fueling community debate on whether persistent inflation or geopolitical de-escalation will dictate the path for long-term Treasury yields and future rate cuts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Legend Biotech Q4 Earnings Call Highlights

Legend Biotech (NASDAQ:LEGN) executives highlighted accelerating global demand for CARVYKTI, improving profitability metrics, and expanding manufacturing capacity during the company's fourth quarter...

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Consensus Rating of "Moderate Buy" by Analysts

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the sixteen research firms that are presently covering the...

Triata Capital Ltd Purchases 54,300 Shares of Legend Biotech Corporation Sponsored ADR $LEGN

Triata Capital Ltd grew its position in shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) by 50.5% during the third quarter, according to the company in its most recent...

Legend Biotech (NASDAQ:LEGN) Trading Up 5.5% - Here's Why

Legend Biotech (NASDAQ:LEGN) Shares Up 5.5% - Time to Buy...

Legend Biotech (LEGN) Projected to Post Earnings on Tuesday

Legend Biotech (NASDAQ:LEGN) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 10. (View Earnings Report at...

Westfield Capital Management Co. LP Lowers Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN

Westfield Capital Management Co. LP trimmed its stake in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) by 5.8% during the third quarter, according to its most recent 13F filing...

Legend Biotech (NASDAQ:LEGN) Downgraded to "Hold" Rating by Truist Financial

Truist Financial lowered shares of Legend Biotech from a "strong-buy" rating to a "hold" rating in a research note on Monday...

Legend Biotech (NASDAQ:LEGN) Shares Gap Up - Still a Buy?

Legend Biotech (NASDAQ:LEGN) Shares Gap Up - Here's Why...

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Average Rating of "Moderate Buy" by Brokerages

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Get Free Report) has been given a consensus rating of "Moderate Buy" by the sixteen brokerages that are presently covering the firm, Marketbeat...

Legend Biotech (NASDAQ:LEGN) Lowered to "Neutral" Rating by Rothschild & Co Redburn

Rothschild & Co Redburn downgraded shares of Legend Biotech from a "buy" rating to a "neutral" rating and set a $24.00 price target on the stock. in a report on Thursday...

$LEGN Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.16 down -214.29% YoY
• Reported revenue of $306.3M up 64.24% YoY
• Legend Biotech expects to achieve a company-wide operating profit beyond 2026, supported by its strong balance sheet with $949 million in cash and cash equivalents as of December 31, 2025.

Stocktwits

Legend Biotech

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of -$0.16 down -214.29% YoY
• Reported revenue of $306.3M up 64.24% YoY
• Legend Biotech expects to achieve a company-wide operating profit beyond 2026, supported by its strong balance sheet with $949 million in cash and cash equivalents as of December 31, 2025.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Current Price	$20.00
Prev Close	$19.56
Open	$19.82
Dividend Yield	0.00%
50-Day Moving Average	$19.60
Beta	0.50
Avg. Volume	2.41M
PE Ratio	-14.98

52-Week High	$45.30
52-Week Low	$16.24
Market Capitalization	$3.61B
EPS (Annual)	-$1.61
Price to Book	3.57
Revenue Per Employee	$395,408.65

LEGN
Legend Biotech

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LEGN News

LEGNLegend Biotech